Withdrawal of prophylaxis against Pneumocystis carinii pneumonia
- 1 April 1999
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 353 (9161) , 1287
- https://doi.org/10.1016/s0140-6736(99)00123-3
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapyThe Lancet, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: A composite of redistribution and proliferationNature Medicine, 1998
- A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or LessNew England Journal of Medicine, 1997
- Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV DiseaseScience, 1997
- Impact of Combination Therapy for HIV Infection on Inpatient CensusNew England Journal of Medicine, 1997
- The Risk ofPneumocystis cariniiPneumonia among Men Infected with Human Immunodeficiency Virus Type 1New England Journal of Medicine, 1990